The largest database of trusted experimental protocols

11 protocols using big dye terminator version 3.1 kit

1

Genotyping of IL-10 SNPs in Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from 300 μL EDTA-treated whole blood using a Commercial kit (Wizard genomic DNA purification kit, Promega, WI, USA). The procedure was carried according to the kit manufacturer's recommendation.
Genotyping analysis for detection of 3 SNPs of IL-10s was performed for all patients by using specific PCR primers. Table 1 describes primers used and PCR conditions. PCR was performed in a total volume of 25 μL using 100 ng of genomic DNA with 1.5 μL of 10 μmol/L of each primer and 12.5 μL of 2X KAPA2G Fast ReadyMix PCR Kit (Kappa Biosystems, USA). PCR amplifications were performed in PTC-100 Peltier Thermal Cycler (MJ Research, MA, USA).
PCR reaction products were sequenced using Big Dye Terminator version 3.1 kit (Applied Biosystems, Waltham, MA, USA). Samples were run on an ABI Prism Genetic Analyzer system 3130xl (Applied Biosystems, Waltham, MA, USA).
+ Open protocol
+ Expand
2

Verification of PCR Amplicons by Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-PCR was carried out in a Thermal Cycler (Applied Biosystems, Foster City, CA) in order to verify the three PCR amplicons (SsrA, RsaC and RNAIII) by agarose gel and DNA sequencing. The PCR was performed in a 20 μL reaction, containing gene-specific primers mentioned above and DreamTaq Green PCR Master Mix (Thermo Fischer Scientific, USA) according to the manufacturer's instruction. One μL of cDNA was used as the template. The cycling conditions were performed as follows: after an initial denaturation step of 2 min at 95 °C, 40 cycles were performed for 30 s at 95 °C, 60 s at 60 °C, and 1 min at 72 °C. A final extension step for 10 min at 72 °C was used. PCR products were further separated on a 1% agarose gel, stained with GelRed and visualized using Syngen Gel Imaging (Bio-Rad Laboratories Inc, USA). The PCR product was cleaned using PCR Clean-Up Kit (Promega, Norway). Sequencing reactions were performed in using a BigDye Terminator version 3.1 kit (Applied Biosystems) according to the manufacturer's instructions with the same primers as for the real-time PCR assay. Sequencing was performed on an Applied Biosystems 3,130 × l genetic analyzer.
+ Open protocol
+ Expand
3

Genetic Screening for Neuromuscular Disorders

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from leukocytes by standard methods. At the beginning of the investigations, 13 patients were tested for congenital myotonia (CLCN1, at least the 3 most common mutations in Finland), 14 for DM2 (CNBP repeat expansion mutation), and 2 for DM1 (DMPK repeat expansion mutation). There was a heterozygous known recessive mutation in CLCN1 gene in 2 patients, whereas other results were negative. For all patients but one (P13), the whole coding sequence of exon 19 of SCN4A was screened. The region studied was amplified by PCR and directly sequenced with the Big-Dye Terminator version 3.1 kit on an ABI3130xl automatic DNA sequencer system (Applied Biosystems, Foster City, CA). Sequences were analyzed with Sequencher 5.1 software (Gene Codes Corporation, Ann Arbor, MI). The primers used are available on request. For P13, the genetic analysis was performed using targeted next-generation sequencing as previously described12 (link) with version 2 of the MYOcap gene panel that is targeted to the exons of 236 genes known or predicted to cause muscular dystrophy or myopathy.
+ Open protocol
+ Expand
4

Amplification and Sequencing of XRCC Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PCR amplifications targeting the XRCC1-exon-10, XRCC3-exon-7 and XRCC3-5’-UTR regions were performed using specific primers based on the XRCC1 and XRCC3 sequences obtained from the National Center for Biotechnology Information (NCBI) (Table 1). The PCR amplification was performed in 30 µl reaction volume that contained (75 mM Tris-HCl, 1.5 mM MgCls, 50 mM KCl, 20 mM (NH4) 2SO4, 0.2 mM of each primer and 1 U of Taq DNA polymerase). Polymerase chain reactions were conducted under the following cycling conditions: an initial 7 minutes of denaturation at 95°C followed by 45 cycles for 45 seconds each at 94°C, 59°C, 72°C for 1 minute, and a single final extension step for 10 minutes at 72°C. Direct DNA sequencing was performed using Big Dye Terminator version 3.1 kit (Applied Biosystems, Waltham, MA, USA). Samples were run on an ABI Prism Genetic Analyzer system 3130xl (Applied Biosystems, Waltham, MA, USA).
+ Open protocol
+ Expand
5

Bisulfite PCR and Sequencing of miR31 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
A GpC site in the promoter locus of the miR31 host gene (LOC554202), which was previously demonstrated [21] (link), was PCR-amplified using bisulfate-treated genomic DNA as a template, according to the method described elsewhere [21] (link). The PCR product was sub-cloned into the pT7 blue plasmid vector (Novagen, Darmstadt, Germany), and was then subjected to a cycle dye-terminator reaction with the universal T7 promoter primer using the Big Dye Terminator Version 3.1 kit (Applied Biosystems, Foster City, CA).
+ Open protocol
+ Expand
6

Pestivirus Detection in Chamois

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viral RNA was extracted from chamois spleen tissues using a commercial RNA extraction kit (Nucleospin Viral RNA Isolation, Macherey Nagel, Düren, Germany). Reverse transcription and PCR assays targeting 5’UTR region of pestivirus were performed using 324 and 326 pan-pestivirus primers [37 (link)] following previously described protocols [32 (link)]. For each sample, amplicons of the expected size were purified and sequenced using forward and reverse primers by cycle sequencing using a Big Dye Terminator version 3.1 kit and an ABI PRISM 3130xl sequencing device (Applied Biosystems, CA, USA).
All sequences from chamois and domestic hosts were aligned with BDV reference strains, retrieved from GenBank and representative of BDV phylogenetic groups according to [12 (link)], using CLUSTALW (integrated within the Bio-Edit sequence editor, freely available at http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Phylogeny was preliminary estimated by the neighbor-joining algorithm (NJ) and the maximum likelihood (ML) method.
+ Open protocol
+ Expand
7

Sequencing for Discordant TB Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sanger sequencing was performed whenever results between MTBDRplus and phenotypic DST remained discordant upon repeating both tests. Isolates showing conflicting results for INH had the mabA-inhA regulatory region (positions -168 to 80, relative to codon) amplified and sequenced with primers mabA-inhAF and mabA-inhAR,16) as well as the entire inhA and katG genes by using the primer pairs inhA3 and inhA4, inhA3F and inhA5R, and the forward and reverse primers katG-P4, -P5, -P6, -P7 and -P8.17 For isolates with RIF-discordant results, primers RPOB-1 and RPOB-218) were used to amplify and sequence a 350-bp fragment of rpoB encompassing the RIF resistance-determining region.
Single PCR included 12.5 µL of PrimeSTAR Max DNA Polymerase (Takara Bio, Shiga, Japan), 5 pmol of primers for mabA-inhA and katG, 10 pmol of primers for inhA and rpoB, 2 µL of DNA template and PCR-grade water for a final volume of 25 µL. Amplification comprised 30 cycles of 98 °C for 10 seconds, 55 °C for 5 seconds, and 72 °C for 20 seconds. Amplimers purified with ExoSAP-it (Affymetrix, SCL, CA, USA) were sequenced with an ABI 3130xL Genetic Analyzer and the BigDye Terminator version 3.1 Kit (Applied Biosystems, FSTC, CA, USA). Sequences were aligned and analysed using the BioEdit v7.2.5 software19 and the web-based MUBII-TB-DB20 and BLAST21 tools.
+ Open protocol
+ Expand
8

DNA Purification and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PCR products were purified from the agarose gel by using Nucleospin @ Extract II kit (Macherey-Nagel, Germany) as per manufacturer's recommended protocol. DNA (200 ng of gel-purified product) was used with the Big Dye Terminator kit (version 3.1) (Applied Biosystem, Foster City, CA, USA) for the sequencing PCR. The template was purified and sequenced on a 3130xl Genetic Analyzer (Applied Biosystem, Foster City, CA, USA).
+ Open protocol
+ Expand
9

DNA Sequencing Protocol Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amplified fragments were firstly purified using the illustra ExoProStar1-Step (GE Healthcare Life Sciences). Direct sequencing of amplicons was performed using Big Dye Terminator kit (version 3.1) (Applied Biosystem, Foster City, CA, USA) that includes dideoxynucleotides labelled with four fluorochromes of different colours. For each PCR product, both strands were sequenced, in independent reactions, using the mentioned above primers. The resulting chromatograms were manually edited to ensure sequence accuracy and added to the alignment component of MEGA 5 software.
+ Open protocol
+ Expand
10

Sanger Sequencing for Variant Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Automated Sanger sequencing was carried out to confirm variants of interest and for segregation analysis when familial samples were available. Polymerase chain reaction–amplified regions (primer sequences are available on request) were purified enzymatically with Illustra ExoProStar (GE Healthcare Life Sciences) and sequenced using a BigDye Terminator, version 3.1 kit (Thermo Fisher Scientific) on an ABI 3130x1 automated DNA sequencer (Thermo Fisher).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!